AKRO
Price
$24.45
Change
+$0.06 (+0.25%)
Updated
Mar 27, 6:59 PM EST
47 days until earnings call
ETNB
Price
$11.31
Change
+$0.11 (+0.98%)
Updated
Mar 27, 6:59 PM EST
41 days until earnings call
Ad is loading...

Compare trend and price AKRO vs ETNB

Header iconAKRO vs ETNB Comparison
Open Charts AKRO vs ETNBBanner chart's image
Akero Therapeutics
Price$24.45
Change+$0.06 (+0.25%)
Volume$575.99K
CapitalizationN/A
89bio
Price$11.31
Change+$0.11 (+0.98%)
Volume$718.19K
CapitalizationN/A
View a ticker or compare two or three
AKRO vs ETNB Comparison Chart

Loading...

AKRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
ETNBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AKRO vs. ETNB commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a StrongSell and ETNB is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (AKRO: $24.48 vs. ETNB: $11.31)
Brand notoriety: AKRO and ETNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 48% vs. ETNB: 61%
Market capitalization -- AKRO: $1.69B vs. ETNB: $1.06B
AKRO [@Biotechnology] is valued at $1.69B. ETNB’s [@Biotechnology] market capitalization is $1.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileETNB’s FA Score has 1 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • ETNB’s FA Score: 1 green, 4 red.
According to our system of comparison, both AKRO and ETNB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 5 TA indicator(s) are bullish while ETNB’s TA Score has 6 bullish TA indicator(s).

  • AKRO’s TA Score: 5 bullish, 5 bearish.
  • ETNB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ETNB is a better buy in the short-term than AKRO.

Price Growth

AKRO (@Biotechnology) experienced а -2.82% price change this week, while ETNB (@Biotechnology) price change was -0.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.41%. For the same industry, the average monthly price growth was +5.97%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

AKRO is expected to report earnings on May 14, 2024.

ETNB is expected to report earnings on May 08, 2024.

Industries' Descriptions

@Biotechnology (+4.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AKRO with price predictions.
OPEN
A.I.dvisor published
a Summary for ETNB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AKRO($1.69B) has a higher market cap than ETNB($1.06B). AKRO YTD gains are higher at: 4.839 vs. ETNB (1.253). ETNB has higher annual earnings (EBITDA): -133.48M vs. AKRO (-148.63M). ETNB has more cash in the bank: 579M vs. AKRO (550M). AKRO (26.3M) and ETNB (27.1M) have identical debt. AKRO (0) and ETNB (0) have equivalent revenues.
AKROETNBAKRO / ETNB
Capitalization1.69B1.06B160%
EBITDA-148.63M-133.48M111%
Gain YTD4.8391.253386%
P/E RatioN/AN/A-
Revenue00-
Total Cash550M579M95%
Total Debt26.3M27.1M97%
TECHNICAL ANALYSIS
Technical Analysis
AKROETNB
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 6 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
AKRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
ETNBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CDOFX46.490.91
+2.00%
Crawford Small Cap Dividend
FRDRX94.421.11
+1.19%
Franklin Rising Dividends R
JSLNX19.300.06
+0.31%
Janus Henderson Global Select N
MSERX9.43N/A
N/A
MassMutual Small Cap Growth Eq R4
BRKIX12.92-0.01
-0.08%
MFS Blended Research Em Mkts Eq I

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been closely correlated with ETNB. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
+0.37%
ETNB - AKRO
78%
Closely correlated
+0.98%
VTYX - AKRO
51%
Loosely correlated
-1.02%
AGEN - AKRO
39%
Loosely correlated
+3.73%
AMLX - AKRO
39%
Loosely correlated
+5.11%
INBX - AKRO
38%
Loosely correlated
+0.23%
More

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been closely correlated with AKRO. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+0.98%
AKRO - ETNB
77%
Closely correlated
+0.37%
VTYX - ETNB
37%
Loosely correlated
-1.02%
ORMP - ETNB
33%
Poorly correlated
+4.41%
PRME - ETNB
31%
Poorly correlated
+1.65%
AGIO - ETNB
31%
Poorly correlated
+0.34%
More